Chembond Chemicals Limited

NSE:CHEMBOND.NS

579 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 4,619.8614,404.4413,488.6362,742.012,679.163,009.6643,268.5722,805.242,710.4713,002.2852,703.7622,623.1752,284.5392,067.8121,750.4861,421.8151,313.1821,031.59
Cost of Revenue 3,259.8712,552.9052,243.6041,600.6161,588.2331,851.0272,252.1291,971.8861,920.1761,955.0211,819.7961,793.6681,811.891,815.431,508.8141,309.1361,153.487909.55
Gross Profit 1,359.991,851.5361,245.0321,141.3941,090.9271,158.6371,016.443833.354790.2951,047.264883.966829.507472.649252.382241.672112.68159.696122.04
Gross Profit Ratio 0.2940.420.3570.4160.4070.3850.3110.2970.2920.3490.3270.3160.2070.1220.1380.0790.1220.118
Reseach & Development Expenses 8.34910.01610.8149.6515.40516.49813.41610.7337.48911.9277.7549.526000000
General & Administrative Expenses 147.937126.552101.134100.077104.22889.165108.352110.52451.256138.063129.28841.922000000
Selling & Marketing Expenses 375.918362.281289.278221.642239.71247.23198.333163.35644.287254.279229.79570.821000000
SG&A 922.249488.833390.412321.719343.938336.395306.685273.8895.543392.342359.083112.743000000
Other Expenses 172.62346.36119.8325.6345.812.11112.485.6721.9770.5950.6980.795232.73631.26830.54420.51711.6617.649
Operating Expenses 922.2491,550.8051,107.148964.1721,000.323917.574807.757710.466671.165819.224700.423619.279232.736-26.553-11.785-39.616-5.151-10.891
Operating Income 437.741315.461149.315143.30776.6214.32208.686122.8881,948.4200.789151.898157.676239.913278.935253.457152.296164.847132.931
Operating Income Ratio 0.0950.0720.0430.0520.0290.0710.0640.0440.7190.0670.0560.060.1050.1350.1450.1070.1260.129
Total Other Income Expenses Net 160.85521.10656.064141.9842.32129.73870.34237.7491,829.27-27.25-31.645-52.552-36.408-30.889-30.166-20.138-11.283-7.271
Income Before Tax 598.596336.679205.376285.29278.921244.058279.028160.6371,948.4200.79151.898157.676203.505248.046223.291132.158153.565125.66
Income Before Tax Ratio 0.130.0760.0590.1040.0290.0810.0850.0570.7190.0670.0560.060.0890.120.1280.0930.1170.122
Income Tax Expense 155.43988.95965.51981.20348.07145.69443.3554.542383.66258.259.8480.73667.4586.59675.44343.86649.55249.664
Net Income 444.097250.956139.209203.44318.729173.221219.72377.5531,536.523123.78677.59570.841125.303135.358123.9478.56793.71473.123
Net Income Ratio 0.0960.0570.040.0740.0070.0580.0670.0280.5670.0410.0290.0270.0550.0650.0710.0550.0710.071
EPS 33.0218.3610.3515.131.3912.8816.345.78115.049.35.835.569.8510.649.746.558.286.09
EPS Diluted 33.0218.3610.3515.131.3912.8816.345.78113.299.065.665.549.8510.649.746.558.286.09
EBITDA 493.195392.145203.536242.067159.827300.45275.267184.132425.068274.471211.682236.915260.906297.722271.143166.012175.149141.307
EBITDA Ratio 0.1070.0890.0580.0880.060.10.0840.0660.1570.0910.0780.090.1140.1440.1550.1170.1330.137